# Bupivacaine With Epidural Volume Extension

> **NCT03110003** · PHASE3 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 45 (actual)

## Conditions studied

- Spinal Anesthesia
- Epidural; Anesthesia

## Interventions

- **DRUG:** 10 mg Bupivacaine
- **DRUG:** 5 mg Bupivacaine

## Key facts

- **NCT ID:** NCT03110003
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-27
- **Primary completion:** 2017-12-01
- **Final completion:** 2018-09-30
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110003, "Bupivacaine With Epidural Volume Extension". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03110003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*